Public deck

Zimmer Biomet: medtech durability still has to prove procedure demand, margin quality and cash conversion

ZBH has an annual revenue baseline of $8.2B, latest revenue marker of $2.1B Q1 2026, annual net income of $705.1M and cash of $424.2M. The thesis depends on revenue durability, margins, cash conversion and balance-sheet discipline.